Production of monoclonal antibodies against GPCR using cell-free synthesized GPCR antigen and biotinylated liposome-based interaction assay
Hiroyuki Takeda,Tomio Ogasawara,Tatsuhiko Ozawa,Atsushi Muraguchi,Pei-Ju Jih,Ryo Morishita,Motokazu Uchigashima,Masahiko Watanabe,Toyoshi Fujimoto,Takahiro Iwasaki,Yaeta Endo,Tatsuya Sawasaki
DOI: https://doi.org/10.1038/srep11333
IF: 4.6
2015-06-10
Scientific Reports
Abstract:AbstractG-protein-coupled receptors (GPCRs) are one of the most important drug targets and anti-GPCR monoclonal antibody (mAb) is an essential tool for functional analysis of GPCRs. However, it is very difficult to develop GPCR-specific mAbs due to difficulties in production of recombinant GPCR antigens and lack of efficient mAb screening method. Here we describe a novel approach for the production of mAbs against GPCR using two original methods, bilayer-dialysis method and biotinylated liposome-based interaction assay (BiLIA), both of which are developed using wheat cell-free protein synthesis system and liposome technology. Using bilayer-dialysis method, various GPCRs were successfully synthesized with quality and quantity sufficient for immunization. For selection of specific mAb, we designed BiLIA that detects interaction between antibody and membrane protein on liposome. BiLIA prevented denaturation of GPCR and then preferably selected conformation-sensitive antibodies. Using this approach, we successfully obtained mAbs against DRD1, GHSR, PTGER1 and T1R1. With respect to DRD1 mAb, 36 mouse mAbs and 6 rabbit mAbs were obtained which specifically recognized native DRD1 with high affinity. Among them, half of the mAbs were conformation-sensitive mAb and two mAbs recognized extracellular loop 2 of DRD1. These results indicated that this approach is useful for GPCR mAb production.
multidisciplinary sciences